Best Radiation Oncologists for Intracavitary Brachytherapy in India

Cervical cancer is a malignant tumour arising from the cells of the cervix, most commonly triggered by long-term infection with oncogenic (cancer-causing) strains of HPV. It ranges from early, highly treatable lesions to more advanced disease requiring complex, multi-modal treatment.

Early-stage cervical cancer often causes no noticeable symptoms, which is why routine screening is so important; when symptoms do appear they may include abnormal vaginal bleeding (between periods, after intercourse, or after menopause), unusual vaginal discharge, or pelvic pain. More advanced disease can cause pain in the lower back or legs, swelling of the legs, or difficulty with bladder and bowel function. The presence or absence of these symptoms alone is not sufficient to establish or rule out a diagnosis — a formal clinical evaluation is always necessary.

Diagnosis typically begins with a pelvic examination and cervical screening (such as a Pap smear or liquid-based cytology), often followed by colposcopy and targeted biopsy if abnormal cells are detected. Confirmed cancer is then staged — most commonly using the FIGO (International Federation of Gynaecology and Obstetrics) staging system — which takes into account tumour size, depth of invasion, and spread to lymph nodes or distant sites, assessed through imaging such as MRI, CT, or PET-CT. HPV genotyping and, in some centres, surgical lymph node evaluation may also inform the treatment plan; the exact investigations recommended will depend on individual clinical findings.

Treatment for cervical cancer depends on the stage at diagnosis, the patient's age, overall health, and whether fertility preservation is a consideration. Early-stage disease (particularly pre-invasive or microinvasive lesions) may be managed with minimally invasive excisional procedures such as LLETZ/LEEP or cone biopsy, while localised invasive cancers are frequently treated with radical hysterectomy or with concurrent chemoradiotherapy — a combination of external beam radiation and chemotherapy, often followed by intracavitary brachytherapy to deliver a precise high dose to the cervix and surrounding tissue. Advanced or recurrent disease may require additional systemic therapies, including chemotherapy, targeted agents, or immunotherapy, and all treatment decisions should be made collaboratively with a qualified specialist based on a full individual assessment.

Non-surgical pathways play a central and well-established role in cervical cancer management: concurrent chemoradiotherapy (external beam radiotherapy combined with chemotherapy, typically cisplatin-based) followed by intracavitary brachytherapy is a standard curative-intent treatment for locally advanced disease and is considered equivalent in outcome to surgery for many patients. Immunotherapy and targeted therapy are emerging non-surgical options for recurrent or metastatic disease. That said, the appropriateness of any non-surgical approach — and whether it is used alone or combined with surgery — depends entirely on individual staging and clinical assessment.

Intracavitary Brachytherapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.

Cervical cancer is typically managed by a gynaecologic oncologist (for surgical evaluation and overall case management) working alongside a radiation oncologist (who oversees external beam radiotherapy and brachytherapy) and a medical oncologist (who manages systemic chemotherapy and immunotherapy). Care at a centre with a dedicated multidisciplinary gynaecological oncology tumour board is strongly advisable.

When selecting a provider, look for a gynaecologic oncologist or radiation oncologist with documented experience in cervical cancer treatment — including intracavitary brachytherapy if that modality is likely to be part of your care — affiliated with a centre that offers multidisciplinary tumour board review, advanced imaging, and structured long-term follow-up for surveillance and management of potential late effects.

Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.

Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.